Bill Text: TX HB4561 | 2023-2024 | 88th Legislature | Introduced
Bill Title: Relating to the establishment of the Alternative Mental Health Therapy Research Consortium and to certain plans, programs, and studies related to the provision of those alternative mental health therapies.
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Introduced - Dead) 2023-03-22 - Referred to Public Health [HB4561 Detail]
Download: Texas-2023-HB4561-Introduced.html
88R10398 MPF-D | ||
By: Johnson of Dallas | H.B. No. 4561 |
|
||
|
||
relating to the establishment of the Alternative Mental Health | ||
Therapy Research Consortium and to certain plans, programs, and | ||
studies related to the provision of those alternative mental health | ||
therapies. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Chapter 531, Government Code, is amended by | ||
adding Subchapter I-1 to read as follows: | ||
SUBCHAPTER I-1. ALTERNATIVE MENTAL HEALTH THERAPIES | ||
Sec. 531.331. ALTERNATIVE MENTAL HEALTH THERAPY RESEARCH | ||
CONSORTIUM. (a) In this section, "consortium" means the Texas | ||
Alternative Mental Health Therapy Research Consortium. | ||
(b) The commission shall establish the Texas Alternative | ||
Mental Health Therapy Research Consortium. | ||
(c) The consortium is composed of: | ||
(1) academic scholars with knowledge of the efficacy | ||
of providing mental health therapy using psychedelics; | ||
(2) representatives of health-related institutions | ||
providing alternative mental health therapies using ketamine; | ||
(3) mental health professionals who specialize in | ||
providing mental health care to veterans; and | ||
(4) representatives of an advocacy group for | ||
alternative mental health therapies using psychedelics. | ||
(d) The executive commissioner shall appoint the members of | ||
the consortium. | ||
(e) The consortium shall research the efficacy of providing | ||
mental health care through the provision of psychedelic drugs and | ||
ketamine, focusing on the provision of mental health care to | ||
veterans in this state through the use of those alternative | ||
therapies. | ||
(f) The consortium shall solicit, and the commission may | ||
accept on behalf of the consortium, a gift, grant, or donation made | ||
from any public or private source to accomplish the purposes of this | ||
section. | ||
Sec. 531.332. GRANT PROGRAM FOR KETAMINE CLINICS. (a) The | ||
commission shall establish and administer a grant program to | ||
establish ketamine clinics in this state. | ||
(b) In addition to money appropriated by the legislature, | ||
the commission may accept gifts, grants, or donations from any | ||
source to administer and finance the grant program established | ||
under this section. | ||
Sec. 531.333. PLAN FOR KETAMINE THERAPY VOUCHER PROGRAM FOR | ||
VETERANS. The commission shall develop a plan to establish a | ||
voucher program to provide ketamine therapy to veterans. | ||
Sec. 531.334. RULES. The executive commissioner shall | ||
adopt rules to implement this subchapter. | ||
SECTION 2. (a) The Health and Human Services Commission | ||
shall conduct a study to evaluate the efficacy of using alternative | ||
therapies, including the use of ibogaine and 5-MeO-DMT, to treat | ||
veterans who suffer from post-traumatic stress disorder, | ||
depression, and mild traumatic brain injury. | ||
(b) As part of the study conducted under Subsection (a) of | ||
this section, the commission must review scientific literature | ||
related to alternative therapies. | ||
(c) Not later than December 1, 2024, the Health and Human | ||
Services Commission shall prepare and submit a report to the | ||
legislature containing the findings of the study and any | ||
recommendations for legislative action. | ||
(d) This section expires September 1, 2025. | ||
SECTION 3. This Act takes effect September 1, 2023. |